Sampre Nutrition

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: INE375C01022
  • NSEID:
  • BSEID: 530617
INR
5.59
0.25 (4.68%)
BSENSE

Aug 10

BSE+NSE Vol: 3.55 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 981259,
    "name": "Sampre Nutrition",
    "stock_name": "Sampre Nutrition",
    "full_name": "Sampre Nutritions Ltd",
    "name_url": "stocks-analysis/sampre-nutrition",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.59",
    "chg": 0.25,
    "chgp": "4.68%",
    "dir": 1,
    "prev_price": "5.34",
    "mcapval": "53.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530617,
    "symbol": "",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "India SENSEX",
    "isin": "INE375C01022",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "3.55 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sampre-nutrition-981259-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 10,
    "sid": "981259",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sampre-nutritions-981259"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Newspaper publication of the unaudited standalone and consolidated financial results of the company for the first quarter ended 30 June 2026 for the financial year 2026-27.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Audited Financial Results For The First Quarter Ended 30 June 2026 Approval Of AGM Notice And Proposal To Revise Remuneration For Vishal Ratan Gurbani",
      "datetime": "05-Aug-2026",
      "details": "(i) In compliance with Regulation 33 of the SEBI (LODR) Regulations 2015 the unaudited standalone and consolidated financial results along with the limited review report is attached for the first quarter ended 30 June 2026 for the financial year 2026-27; (ii) Approval of the 35th AGM of the Company to be held on VC/OAVM Mode on Friday 04 September 2026 at 11:00 A.M. (IST); and (iii) Proposal to revise the remuneration to Vishal Ratan Gurbani Whole-time Director of the Company from INR 18 Lakhs per annum to INR 60 Lakhs per annum with effect from 01 April 2026 subject to the approval of the members of the company in the ensuing AGM.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approving Q1 Results Finalising The AGM Notice; And Proposal To Increase The Remuneration For Vishal Gurbani Whole-Time Director From INR 18 Lakhs Per Annum To INR 60 Lakhs Per Annum.",
      "datetime": "31-Jul-2026",
      "details": "Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve 1. Unaudited standalone and consolidated financial results of the Company for the first quarter ended 30 June 2026 for the financial year 2026-27. 2. Fix the date time and venue for the Thirty-Fifth (35th) Annual General Meeting (AGM) of the Company and to approve the Notice of AGM and other matters connected therewith. 3. Proposal to increase the remuneration for Vishal Gurbani (DIN: 07738685) Whole-Time Director of the Company from INR 1800000 (Indian Rupees Eighteen Lakhs) only per annum to INR 6000000 (Indian Rupees Sixty Lakhs) only per annum with effect from 01 April 2026 subject to the approval of the members at the ensuing AGM of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>5:10</strong> stock split, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Aug-2026 | Source : BSE

Newspaper publication of the unaudited standalone and consolidated financial results of the company for the first quarter ended 30 June 2026 for the financial year 2026-27.

Board Meeting Outcome for Audited Financial Results For The First Quarter Ended 30 June 2026 Approval Of AGM Notice And Proposal To Revise Remuneration For Vishal Ratan Gurbani

05-Aug-2026 | Source : BSE

(i) In compliance with Regulation 33 of the SEBI (LODR) Regulations 2015 the unaudited standalone and consolidated financial results along with the limited review report is attached for the first quarter ended 30 June 2026 for the financial year 2026-27; (ii) Approval of the 35th AGM of the Company to be held on VC/OAVM Mode on Friday 04 September 2026 at 11:00 A.M. (IST); and (iii) Proposal to revise the remuneration to Vishal Ratan Gurbani Whole-time Director of the Company from INR 18 Lakhs per annum to INR 60 Lakhs per annum with effect from 01 April 2026 subject to the approval of the members of the company in the ensuing AGM.

Board Meeting Intimation for Approving Q1 Results Finalising The AGM Notice; And Proposal To Increase The Remuneration For Vishal Gurbani Whole-Time Director From INR 18 Lakhs Per Annum To INR 60 Lakhs Per Annum.

31-Jul-2026 | Source : BSE

Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve 1. Unaudited standalone and consolidated financial results of the Company for the first quarter ended 30 June 2026 for the financial year 2026-27. 2. Fix the date time and venue for the Thirty-Fifth (35th) Annual General Meeting (AGM) of the Company and to approve the Notice of AGM and other matters connected therewith. 3. Proposal to increase the remuneration for Vishal Gurbani (DIN: 07738685) Whole-Time Director of the Company from INR 1800000 (Indian Rupees Eighteen Lakhs) only per annum to INR 6000000 (Indian Rupees Sixty Lakhs) only per annum with effect from 01 April 2026 subject to the approval of the members at the ensuing AGM of the Company.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Sampre Nutritions Ltd has announced 5:10 stock split, ex-date: 14 Nov 25

stock-summary
BONUS

Sampre Nutritions Ltd has announced 1:1 bonus issue, ex-date: 14 Nov 25

stock-summary
RIGHTS

No Rights history available